The determination of CKMB is an important element in the diagnosis of myocardiac ischemia. CKMB is detectable in the blood about 3-8 hours after the onset of cardiac symptoms and can be detectable over a period of time which is dependant on the course of the condition.
Test principle
Sandwich principle
- 1st incubation: 15uL of sample, a biotinlylated monoclonal anti CK-MB antibody, and a monoclonal CK-MB specific antibody labeled with a ruthenium complex react to form a sandwich complex.
- 2nd incubation: After addition of streptavidin-coated microparticles, the complex becomes bound to the solid phase via interaction of biotin and streptavidin
- The reaction mixture is aspirated into the measuring cell where the microparticles are magnetically captured onto the surface of the electrode. Unbound substances are then washed away.
- Results are determined bia a calibration curve which is instrument-specifically generated by 2 point calibration and a master curve provided via the reagent barcode.
Note: The entire test is done using the analyzer (Cobas e) and the test principle can be found inside the CK-MB kit.
Stanley
Hello Stanley!
ReplyDeleteDo you do direct or indirect ELISA for this test?
Felicia
0703345I
Hello Stanley!
ReplyDeleteAre there any limitations to this test? Like, any factors that will hinder the processing of the results?
Qingling
0703433c
I am really sorry for the late replies.
ReplyDeleteHi Felicia,
I am using a sandwich ELISA for this test.
Hi Qingling,
Patients recieving therapy with high biotin doses such as more than 5mg/day should not be tested for CK-MB as it might due to inaccuracy.
I hope this helps =)
Stanley